Literature DB >> 23878787

Targeted Gene Therapy of Cancer: Second Amendment toward Holistic Therapy.

Jaleh Barar1, Yadollah Omidi.   

Abstract

It seems solid tumors are developing smart organs with specialized cells creating specified bio-territory, the so called "tumor microenvironment (TME)", in which there is reciprocal crosstalk among cancer cells, immune system cells and stromal cells. TME as an intricate milieu also consists of cancer stem cells (CSCs) that can resist against chemotherapies. In solid tumors, metabolism and vascularization appears to be aberrant and tumor interstitial fluid (TIF) functions as physiologic barrier. Thus, chemotherapy, immunotherapy and gene therapy often fail to provide cogent clinical outcomes. It looms that it is the time to accept the fact that initiation of cancer could be generation of another form of life that involves a cluster of thousands of genes, while we have failed to observe all aspects of it. Hence, the current treatment modalities need to be re-visited to cover all key aspects of disease using combination therapy based on the condition of patients. Perhaps personalized cluster of genes need to be simultaneously targeted.

Entities:  

Keywords:  Cancer; Holistic Therapy; Targeted Gene Therapy

Year:  2013        PMID: 23878787      PMCID: PMC3713870          DOI: 10.5681/bi.2013.014

Source DB:  PubMed          Journal:  Bioimpacts        ISSN: 2228-5652


  20 in total

1.  Gene therapy. Repair kits for faulty genes.

Authors:  D Ferber
Journal:  Science       Date:  2001-11-23       Impact factor: 47.728

Review 2.  Antisense molecules for targeted cancer therapy.

Authors:  V Wacheck; U Zangemeister-Wittke
Journal:  Crit Rev Oncol Hematol       Date:  2006-06-05       Impact factor: 6.312

3.  Epigenetics: Unravelling the cancer code.

Authors:  Vicki Brower
Journal:  Nature       Date:  2011-03-24       Impact factor: 49.962

4.  Microarray analysis of the toxicogenomics and the genotoxic potential of a cationic lipid-based gene delivery nanosystem in human alveolar epithelial a549 cells.

Authors:  Yadollah Omidi; Jaleh Barar; Hamid Reza Heidari; Somaieh Ahmadian; Hossein Ahmadpour Yazdi; Saghir Akhtar
Journal:  Toxicol Mech Methods       Date:  2008       Impact factor: 2.987

Review 5.  siRNA-based approaches in cancer therapy.

Authors:  G R Devi
Journal:  Cancer Gene Ther       Date:  2006-01-20       Impact factor: 5.987

6.  Toxicogenomics of non-viral vectors for gene therapy: a microarray study of lipofectin- and oligofectamine-induced gene expression changes in human epithelial cells.

Authors:  Yadollah Omidi; Andrew J Hollins; Mustapha Benboubetra; Ross Drayton; Ibrahim F Benter; Saghir Akhtar
Journal:  J Drug Target       Date:  2003-07       Impact factor: 5.121

7.  Translational Approaches towards Cancer Gene Therapy: Hurdles and Hopes.

Authors:  Jaleh Barar; Yadollah Omidi
Journal:  Bioimpacts       Date:  2012-09-22

8.  Cytotoxic impacts of linear and branched polyethylenimine nanostructures in a431 cells.

Authors:  Vala Kafil; Yadollah Omidi
Journal:  Bioimpacts       Date:  2011-06-09

Review 9.  Gene therapy for brain cancer: combination therapies provide enhanced efficacy and safety.

Authors:  Marianela Candolfi; Kurt M Kroeger; A K M G Muhammad; Kader Yagiz; Catherine Farrokhi; Robert N Pechnick; Pedro R Lowenstein; Maria G Castro
Journal:  Curr Gene Ther       Date:  2009-10       Impact factor: 4.391

10.  Combination treatment of human umbilical cord matrix stem cell-based interferon-beta gene therapy and 5-fluorouracil significantly reduces growth of metastatic human breast cancer in SCID mouse lungs.

Authors:  Raja Shekar Rachakatla; Marla M Pyle; Rie Ayuzawa; Sarah M Edwards; Frank C Marini; Mark L Weiss; Masaaki Tamura; Deryl Troyer
Journal:  Cancer Invest       Date:  2008-08       Impact factor: 2.176

View more
  4 in total

Review 1.  Solid Lipid Nanoparticles as Efficient Drug and Gene Delivery Systems: Recent Breakthroughs.

Authors:  Jafar Ezzati Nazhad Dolatabadi; Hadi Valizadeh; Hamed Hamishehkar
Journal:  Adv Pharm Bull       Date:  2015-06-15

Review 2.  Molecular machineries of pH dysregulation in tumor microenvironment: potential targets for cancer therapy.

Authors:  Mohammad Reza Asgharzadeh; Jaleh Barar; Mohammad M Pourseif; Morteza Eskandani; Mojtaba Jafari Niya; Mohammad Reza Mashayekhi; Yadollah Omidi
Journal:  Bioimpacts       Date:  2017-06-07

3.  A prospective highlight on exosomal nanoshuttles and cancer immunotherapy and vaccination.

Authors:  Mohammad A Rafi; Yadollah Omidi
Journal:  Bioimpacts       Date:  2015-09-10

Review 4.  Targeting tumor microenvironment: crossing tumor interstitial fluid by multifunctional nanomedicines.

Authors:  Yadollah Omidi; Jaleh Barar
Journal:  Bioimpacts       Date:  2014-06-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.